Alerje Earns $1M Phase II SBIR NSF Award to Support Life Changing Food Allergy Immunotherapy for Food Allergies with AI Powered App Platform
A $1,000,000 Phase II SBIR grant from the NSF advances Alerje's efforts to support food allergy immunotherapy (i.e. OIT, SLIT, etc), employing a patent-pending AI-driven platform. Alerje's patent-pending machine learning engine - a key component in ...